Provided by Tiger Trade Technology Pte. Ltd.

Global X Aging Population ETF

39.10
+0.27440.71%
Post-market: 39.08-0.0200-0.05%19:30 EDT
Volume:2K
Turnover:85.60K
Market Cap:96.57M
PE:- -
High:39.10
Open:38.94
Low:38.82
Close:38.83
52wk High:39.48
52wk Low:32.44
Shares:2.47M
Float Shares:2.47M
Volume Ratio:0.20
T/O Rate:0.09%
Dividend:0.33
Dividend Rate:0.83%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

The Mediterranean Diet is the Best One Out There. Here's Why Americans Struggle with It.

Dow Jones
·
Aug 17

Eli Lilly Launches New Phase III Trial in China for Its Once-Daily Depression Candidate

Stock News
·
Aug 17

TYK Medicines Clarifies Board Structure and Committee Roles

TIPRANKS
·
Aug 17

Ventas Announces Availability of 2025-2026 Corporate Sustainability Report

Reuters
·
Aug 17

Top Premarket Gainers

MT Newswires Live
·
Aug 17

Abbvie, Inc. : Wells Fargo Raises Target Price to $300 from $295

THOMSON REUTERS
·
Aug 17

OmniAb Signs Global Ion Channel Collaboration Deal with Eli Lilly, Eyes up to $370 Million in Milestones

Reuters
·
Aug 17

Nancheng County Market Watch Intensifies Medical Supply Checks at Village Clinics

Deep News
·
Aug 17

Global Asset Allocation Enters the "De-Crowding" Era: Bank of America Shifts from AI Computing to Value, Biotech, and Commodities in Search of "Non-Consensus Alpha"

Stock News
·
Aug 17

Welltower Stock And Other Defensive REITs for Steady Income in a Slowing US Economy

Simply Wall St.
·
Aug 16

Bristol Gate’s Richard Hamm Trims Eli Lilly Stake

TIPRANKS
·
Aug 15

Mirova US LLC trims Eli Lilly position by 14,395 shares

TIPRANKS
·
Aug 15

PRIMECAP Management Co trims Eli Lilly stake by 50K

TIPRANKS
·
Aug 15

Insulet Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 15

Eli Lilly & Co. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 15

Eli Lilly’s New Phase 1 Study Signals Ongoing Pipeline Expansion

TIPRANKS
·
Aug 15

Lilly Expands Obesity Pipeline With Fresh Macupatide Trial in Japan

TIPRANKS
·
Aug 15

AbbVie Wraps Real‑World China Study on Upadacitinib in Atopic Dermatitis: What Investors Should Watch

TIPRANKS
·
Aug 15

China Merchants Adjusts Eli Lilly Price Target to $1,252 From $964, Maintains Buy Rating

MT Newswires Live
·
Aug 14

UBS Pursues Dual Strategy in Q2: Betting on AI Compute Boom While Hedging Crowded Trade Risks

Stock News
·
Aug 14